Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease

<p>Multiple myeloma is a fatal haematological malignancy, in which the majority of patients either present with or develop a destructive and debilitating osteolytic bone disease. The bone disease is characterised by an increase in osteoclastogenesis and by osteoblast suppression. Current trea...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteur: Leng, H
Andere auteurs: Simon, K
Formaat: Thesis
Taal:English
Gepubliceerd in: 2019
Onderwerpen:

Gelijkaardige items